Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Goodwill (2016 - 2025)

United Therapeutics (UTHR) has disclosed Goodwill for 16 consecutive years, with $32.3 million as the latest value for Q4 2025.

  • Quarterly Goodwill changed 0.0% to $32.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32.3 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $32.3 million for FY2025, 0.0% changed from the prior year.
  • Goodwill hit $32.3 million in Q4 2025 for United Therapeutics, roughly flat from $32.3 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $33.7 million in Q4 2023 to a low of $4.3 million in Q3 2024.
  • Historically, Goodwill has averaged $27.2 million across 5 years, with a median of $28.0 million in 2021.
  • Biggest five-year swings in Goodwill: grew 20.36% in 2023 and later dropped 4.15% in 2024.
  • Year by year, Goodwill stood at $28.0 million in 2021, then changed by 0.0% to $28.0 million in 2022, then rose by 20.36% to $33.7 million in 2023, then decreased by 4.15% to $32.3 million in 2024, then changed by 0.0% to $32.3 million in 2025.
  • Business Quant data shows Goodwill for UTHR at $32.3 million in Q4 2025, $32.3 million in Q4 2024, and $4.3 million in Q3 2024.